Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study

OBJECTIVES/METHODS: This 1-yr prospective phase II trial evaluated the efficacy of deferasirox in regularly transfused patients aged 3–81 yrs with myelodysplastic syndromes (MDS; n = 47), Diamond–Blackfan anaemia (DBA; n = 30), other rare anaemias (n = 22) or β-thalassaemia (n = 85). Dosage was dete...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Porter, John, Galanello, Renzo, Saglio, Giuseppe, Neufeld, Ellis J, Vichinsky, Elliott, Cappellini, Maria Domenica, Olivieri, Nancy, Piga, Antonio, Cunningham, Melody J, Soulières, Denis, Gattermann, Norbert, Tchernia, Gilbert, Maertens, Johan, Giardina, Patricia, Kwiatkowski, Janet, Quarta, Giovanni, Jeng, Michael, Forni, Gian Luca, Stadler, Michael, Cario, Holger, Debusscher, Louisette, Porta, Matteo Della, Cazzola, Mario, Greenberg, Peter, Alimena, Giuliana, Rabault, Bertrand, Gathmann, Insa, Ford, John Malcolm, Alberti, Daniele, Rose, Christian
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 2008
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2268958/
https://ncbi.nlm.nih.gov/pubmed/18028431
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1600-0609.2007.00985.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars